Lastly, another panel that included adiponectin, resistin and cleaved CK‐18 had good accuracy in the test group (AUROC 0.91) though this dropped significantly in the validation group (0.73) to assess for NASH.43 This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.